Avenga’s response to the war on Ukraine: Business Continuity and Humanitarian Aid
Avenga is a technology partner to the leading pharmaceutical, biotech and medical firms, contract research organizations (CROs), clinical research institutions, and pharmacovigilance vendors in transforming the future of the pharmaceutical industry.
years is the average length for the clinical trial research phase.
Source: Chi-Jen Lee, Clinical Trials of Drugs and Biopharmaceuticals
of clinical trials do not manage to recruit and retain enough patients and fail to meet enrollment timelines.
Source: Clinical trial delays: America’s patient recruitment dilemma
is the total cost of developing one new drug and making it through the FDA approval phase.
Source: Duggan & Pence, Approval Rate for Drugs Entering Clinical Development, 2019
Custom software development for preclinical & clinical trials, drug commercialization, manufacturing, distribution, and safety.
Accelerate your commercial drug development and regulatory processes with a secure and complaint preclinical & clinical trial management software, such as:
Stay organized, maintain strict quality management and streamline pharma manufacturing to meet client’s specifications and regulatory requirements with the help of:
Streamline the flow of ordering, selling, warehousing and shipping pharmaceutical and life sciences products with the help of:
Build pharmacovigilance software or drug safety solutions that lower your operational costs and are fully compliant with pharmaceutical regulations with the help of:
We created for you a 25-pager whitepaper discussing the most important new technologies that are transforming the clinical trial processes. Explore how digital tools for clinical trial management can help you to bring treatment to patients faster and with a lower cost.
Do you need to speed up drug development cycles, introduce real-time insights on sales and user data, enhance operational efficiency, engage customers, improve control and security compliance, and deliver first-rate patient outcomes?
We, at Avenga, deliver full-spectrum services to Life Science and Pharma enterprises globally and make innovation happen. We help our clients drive digital transformation to face tomorrow’s challenges in introducing new drugs, and to cure what is not curable today.
more clinical trials using biomarkers are likely to get approved.
Source: Wong, C., Estimation of clinical trial success rates, 2018
of novel molecular treatments that were approved by the FDA in 2018 were precision medicines.
Source: FDA, New Drug Therapy Approvals, 2019
tech giants are diversifying in pharma and healthcare.
Source: Deloitte, Global Life Sciences Outlook, 2019
See how we reshaped the business of global Pharma and Life Science providers by helping them to deliver improved patient outcomes through digital services.
A set of mature telehealth applications integrated in the health cost containment and care management platform.
Group millions of patients globally to negotiate the lowest drug prices possible.
Access terabytes of well-structured data on clinical trials in real-time.
We help pharma & life sciences organizations develop software for the entire pharmaceutical lifecycle, starting from the component research to drug approval. Our goal is to help our clients optimize their current business processes and bring drugs to market faster.
Expand your business with bespoke apps and software for pharmaceutical sales and marketing departments. Avenga offers tailor-made solutions for the healthcare and pharma industry to foster the sector-specific customer experience and greatly improve your business productivity.
Explore how technology can equip and complement biotech and pharma companies seeking out facilities to run their clinical trials with the utmost efficiency and to move new treatments to the market faster than the competition
CRM solutions in healthcare ensure a flawless experience across the whole customer care lifecycle, starting from the very first contact to subscription, along with sales and marketing, registration, health care delivery, and customer retention.
CRM software for pharma drives your success in the ever-changing market with effective customer-centric services. Pharma CRM facilitates the drug discovery and clinical trial processes, warrants the highest productivity and helps to keep an eye on investments, while also keeping aligned with policies and regulations.
Telemedicine is about technology meeting healthcare. With mHealth, eHealth, telemedicine and Remote Patient Monitoring (RPM) solutions, clinicians and healthcare providers can actualize effective care coordination, mitigate risks of the pandemic spreading, support a HIPAA-compliant access to medical services, streamline clinical trials and optimize expenses.
Affordability and depth of expertise have made them a critical development partner. Their team easily scales to accommodate project size and is equally flexible with scheduling across time zones.
They were a great partner. In the three years I partnered with them − on no less than four projects for three separate companies − I was always impressed with their employees’ professionalism and focus on excellence. I did not view them as vendors, but as teammates.
years of experience
Avenga has a proven track record of delivering excellence for life sciences, pharma, biotech and CRO’s (Contract Research Organizations). For over 15 years, we have maintained and grown ongoing long-term collaborations with the world’s leading pharma & life sciences companies. At Avenga, we combine innovations and technology to tailor and support IT solutions for drug product related operations including clinical trials management, pharma sales enablement, patient engagement portals, industry-specific education, e-prescriptions, integrations with EMR and PMS, legacy systems migration, and a lot more.
Avenga helps you anticipate the trends in biotech & pharma to increase your delivery speed and outcomes. We have the expertise in advanced software development solutions and can fill in your technology gaps with the right people with the right knowledge. We help enterprises redefine the patient experience and incorporate our expertise for life sciences and pharma into a pragmatic value delivery.
Avenga stays abreast of the latest regulations and policies in the pharma and life sciences sector, like FDA, HIPAA, HINTECH, and GDPR. Unlike other product development firms, Avenga software development services are tailored to the highly regulated pharmaceutical & life sciences industry. We understand the complexity of the present-day challenges faced by biotech firms and CROs and implement innovative tech solutions to address these challenges. We meticulously adhere to the strictest Standard Operating Procedures (SOPs) that concern clinical data management and monitoring across all our development stages.
More than 2,500 Avenga professionals across 19 offices are working hard to deliver exceptional impact for our customers and help pharma and life sciences bring discoveries to life. We are proud to have a vast number of software development experts that have already built flexible, compliant and progressive solutions for top pharmaceutical and life sciences companies in the world.
Telehealth has skyrocketed because of the coronavirus pandemic and is relieving the traditional healthcare system from being overwhelmed. Learn more about the telemedicine benefits, how it helps people to tackle the virus and what are the barriers halting telehealth from worldwide adoption.
We are still at least a year away from developing a functional vaccine and controlling the spread of the COVID-19 pandemic. Discover what tools are being developed to tackle the coronavirus disease and how leading pharmaceutical and medical companies have accelerated their efforts to develop vaccines and treatments.
Discover how artificial intelligence (AI), deep learning, advanced analytics and big data are safeguarding us from coronavirus and assist the pharmaceutical industry in clinical trial management and drug development. Can AI assist pharma and biotech with precision medicine, early dose detection, drugs tailored to an individual’s biomarkers?